SC 13D
SC 13D Filing
- Company
- AYTU BIOPHARMA, INC
- Filed
- February 15, 2019
- Accession Number
- 0000919574-19-001855
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →